Daily non-political popular news in brief.
Promising drug fails to improve COPD symptoms
05-01-2007 · EurekAlert!A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease, or COPD, in a large, multicenter trial.
Read more »
Keywords: promising, drug, fails, improve, copd, symptoms, fail, symptom
« Previous | Next »
Similar news on "Promising drug fails to improve COPD symptoms":
- New forecasting tool could reduce drug development costs
02-01-2007 · EurekAlert!
It now costs more than $800 million to develop a new drug. But what if pharmaceutical companies could predict which experimental drugs will ultimately get FDA approval, and which will ultimately fail? Researchers present a forecasting model that could potentially save hundreds of millions of dollars per new drug. They also urge more data sharing by the drug industry to improve the accuracy of forecasting, allowing more medical discoveries to be brought to the bedside.
Similar news · Read more »
- New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis
11-08-2007 · EurekAlert!
The innovative new rheumatoid arthritis drug Actemra has been shown to significantly improve the signs and symptoms of rheumatoid arthritis in patients who failed to achieve an adequate response to traditional disease modifying agents. Exciting new data from the TOWARD1 study, being presented as a late breaker, at the American College of Rheumatology Annual Scientific Meeting in Boston, Nov. 6-11, reinforce the benefit of tackling RA through the inhibition of the IL-6 pathway.
Similar news · Read more »
- Heart failure medication provides some symptom relief
03-25-2007 · EurekAlert!
A medication used to treat heart failure, tolvaptan, appears to improve some symptoms and signs of heart failure during hospitalization, but does not reduce the risk of re-hospitalization or death, according to two articles in the March 28 issue of JAMA. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
Similar news · Read more »
- Promising treatment for post traumatic stress disorder sleep disturbances
04-17-2007 · EurekAlert!
For sufferers of post traumatic stress disorder, sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide. Previously, there has been little success in treating these sleep disorders with psychopharmacologic approaches. In a study in the April 15 issue of Biological Psychiatry, researchers have found that an inexpensive, widely available drug was successful in reducing symptoms in chronic PTSD patients.
Similar news · Read more »
- Promising treatment for post-traumatic stress disorder sleep disturbances
04-17-2007 · EurekAlert!
For sufferers of post-traumatic stress disorder, sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide. Previously, there has been little success in treating these sleep disorders with psychopharmacologic approaches. In a study in the April 15 issue of Biological Psychiatry, researchers have found that an inexpensive, widely available drug was successful in reducing symptoms in chronic PTSD patients.
Similar news · Read more »
- Pilot study shows withdrawal drug offers symptom relief to Crohn's sufferers
02-02-2007 · EurekAlert!
A Penn State College of Medicine pilot study suggests a low dose of naltrexone, a drug used to ease symptoms of alcohol and drug addiction, may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans. The study results were released online this week in an early edition of the American Journal of Gastroenterology.
Similar news · Read more »
- Blood-vessel blocker aids cancer-killing virus
11-27-2007 · EurekAlert!
Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
Similar news · Read more »
- Helping muscle regenerate
11-01-2006 · EurekAlert!
Blocking a central signal molecule, researchers from the Mouse Biology Unit of the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, have found a way to protect muscle from degenerating after injury and to improve muscle healing in mice. The study appears in the current issue of the Journal of Clinical Investigation and suggests molecules with potential to speed up the regeneration of damaged muscle as promising drug targets for new therapies against muscle wasting.
Similar news · Read more »
- Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
10-05-2006 · ScienceDaily
A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
Similar news · Read more »
- Marijuana worsens COPD symptoms in current cigarette smokers
05-21-2007 · EurekAlert!
Marijuana worsens breathing problems in current smokers with chronic obstructive pulmonary disease (COPD), according to a study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
Similar news · Read more »
